You have 9 free searches left this month | for more free features.

idiopathic gastroparesis

Showing 1 - 25 of 2,559

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastroparesis Trial in Baltimore (Pioglitazone 30 mg)

Recruiting
  • Gastroparesis
  • Pioglitazone 30 mg
  • Baltimore, Maryland
    Johns Hopkins Bayview Medical Center
Mar 8, 2022

EGG Abnormalities in Healthy Subjects and in Idiopathic and

Recruiting
  • Gastroparesis
  • +3 more
  • Electrogastrography
  • Hyderabad, Telangana, India
    AIG Hospitals
Nov 14, 2022

Gastroparesis Registry 2

Completed
  • Gastroparesis
  • +2 more
    • Louisville, Kentucky
    • +5 more
    Feb 7, 2022

    Gastroparesis Trial (Naronapride, Placebo)

    Recruiting
    • Gastroparesis
    • Leuven, Belgium
      University of Leuven
    Feb 1, 2023

    Diabetics Without Symptoms of Gastroparesis, Diabetic Gastroparesis, Idiopathic Gastroparesis Trial in Nashville

    Enrolling by invitation
    • Diabetics Without Symptoms of Gastroparesis
    • +5 more
    • magnetogastrogram
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Nov 19, 2021

    Gastroparesis Registry 3

    Recruiting
    • Gastroparesis
    • +2 more
      • Louisville, Kentucky
      • +5 more
      Feb 17, 2022

      Diabetic Gastroparesis, Idiopathic Gastroparesis Trial in Rochester (TAK-954, Placebo)

      Completed
      • Diabetic Gastroparesis
      • Idiopathic Gastroparesis
      • Rochester, Minnesota
        Mayo Clinic
      Dec 16, 2020

      Idiopathic Gastroparesis, Diabetic Gastroparesis Trial in El Paso (Endoscopic Ultrasound Fine Needle Aspiration (EUS-FNA))

      Completed
      • Idiopathic Gastroparesis
      • Diabetic Gastroparesis
      • Endoscopic Ultrasound Fine Needle Aspiration (EUS-FNA)
      • El Paso, Texas
        Texas Tech University HSC at El Paso
      May 26, 2021

      Gastroparesis Postoperative, Gastroparesis Due to Diabetes, Idiopathic Gastric Stasis Trial in Mexico (G-POEM)

      Completed
      • Gastroparesis Postoperative
      • +2 more
      • G-POEM
      • Mexico, Mexico City, Mexico
        Centro Medico Nacional Siglo XXI Hospital de Especialidades
      Jan 5, 2022

      Diabetes and Gastroparesis, Idiopathic Gastroparesis Trial in United States (TAK-906 Maleate, Metaclopramide, TAK-906 Maleate

      Completed
      • Diabetes Mellitus and Gastroparesis, Idiopathic Gastroparesis
      • TAK-906 Maleate
      • +2 more
      • Peoria, Arizona
      • +8 more
      Dec 16, 2020

      Pyloric Sphincter Abnormalities in Gastroparesis Symptoms

      Not yet recruiting
      • Gastroparesis
      • +2 more
        • Louisville, Kentucky
        • +5 more
        Feb 17, 2022

        Diabetic Gastroparesis, Idiopathic Gastroparesis Trial in United States (NG101)

        Active, not recruiting
        • Diabetic Gastroparesis
        • Idiopathic Gastroparesis
        • Dothan, Alabama
        • +82 more
        Nov 4, 2022

        G-POEM for Treatment of Refractory Gastroparesis

        Completed
        • Diabetic Gastroparesis
        • +2 more
        • Gastric Per Oral Endoscopic Myotomy
        • Baltimore, Maryland
          Johns Hopkins Hospital
        Aug 19, 2020

        Gastroparesis Trial (Enterra Gastric Pacemaker)

        Withdrawn
        • Gastroparesis
        • Enterra Gastric Pacemaker
        • (no location specified)
        Mar 3, 2021

        Gastroparesis Trial in United States (CIN-102 Dose 1, CIN-102 Dose 2, CIN-102 Dose 3)

        Completed
        • Gastroparesis
        • CIN-102 Dose 1
        • +3 more
        • Chula Vista, California
        • +18 more
        Jul 16, 2021

        Diabetic Gastroparesis, Idiopathic Gastroparesis Trial in Worldwide (TAK-906 Maleate, TAK-906 Maleate Placebo)

        Completed
        • Diabetic Gastroparesis
        • Idiopathic Gastroparesis
        • TAK-906 Maleate
        • Placebo
        • Dothan, Alabama
        • +108 more
        Oct 24, 2022

        Idiopathic Gastroparesis Trial in United States (Nortriptyline Hydrochloride, Placebo (for nortriptyline))

        Completed
        • Idiopathic Gastroparesis
        • Nortriptyline Hydrochloride
        • Placebo (for nortriptyline)
        • San Francisco, California
        • +6 more
        Apr 30, 2020

        Idiopathic Gastroparesis, Diabetic Gastroparesis, Gastroparesis Trial in United States (Tradipitant, Placebo)

        Recruiting
        • Idiopathic Gastroparesis
        • +2 more
        • Birmingham, Alabama
        • +52 more
        Mar 2, 2021

        Gastroparesis Trial in United States (PCS12852, Placebo)

        Recruiting
        • Gastroparesis
        • Lomita, California
        • +7 more
        Jul 22, 2022

        Gastroparesis, Gastroparesis-like Syndrome Trial in United States

        Not yet recruiting
        • Gastroparesis
        • Gastroparesis-like Syndrome
          • Boston, Massachusetts
          • +5 more
          Aug 1, 2023

          Gastroparesis Registry 4

          Not yet recruiting
          • Gastroparesis
          • +5 more
            • Scottsdale, Arizona
            • +5 more
            May 10, 2023

            Gastroparesis, Gastroparesis Nondiabetic, Gastroparesis Due to Diabetes Trial in Louisville (Enterra™ Therapy System)

            Recruiting
            • Gastroparesis
            • +2 more
            • Enterra™ Therapy System
            • Louisville, Kentucky
              University of Louisville
            Jul 31, 2023

            Idiopathic Gastroparesis Trial in Boston, Ann Arbor (Olanzapine)

            Terminated
            • Idiopathic Gastroparesis
            • Boston, Massachusetts
            • +1 more
            Aug 19, 2019

            Diabetic Gastroparesis Trial

            Not yet recruiting
            • Diabetic Gastroparesis
              • (no location specified)
              Jan 13, 2023

              Pediatric Gastroparesis Registry

              Recruiting
              • Gastroparesis
              • Gastroparesis-like Syndrome
                • Boston, Massachusetts
                • +2 more
                Feb 17, 2022